Search Results 411-420 of 16870 for Antagonist

1. A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia - Mayo Clinic

   interval. 16. Is receiving a concomitant medication that is known to be a strong CYP3A4 inducer, or a centrally acting histamine 1 (H1) receptor antagonist; ...

2. Assessment of Mast Cell Mediators in Pediatric Patients with Clinical Symptoms of Autonomic Dysfunction

   Concomitant therapy with anticholinergic, alpha-adrenergic antagonists, beta-adrenergic antagonists or other medications which could interfere with autonomic ...

3. Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer - Mayo Clinic

   Growth factor antagonists, such as regorafenib, may interfere with the growth factor and stop the tumor from growing. Drugs used in chemotherapy, such as ...

4. Cluster Headache Treatment with Rimegepant - Mayo Clinic

   - Subjects with a history of an adverse reaction to CGRP (calcitonin gene-related peptide) antibodies or another CGRP antagonist (gepant). - Subjects with ...

5. Hematology - Clinical trials

   Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...

6. Clinical trials - Oncology (Medical)

   Anticipated time on study is up to 5 years. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or ...

7. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Is naïve to biologic therapy (TNF antagonists or vedolizumab); Has received biologic therapy but has not demonstrated a history of failure to respond to, or ...

8. Ovarian hyperstimulation syndrome - Diagnosis & treatment - Mayo Clinic

   Sometimes, your provider may also give you other medications, such as gonadotropin-releasing hormone (Gn-RH) antagonist or letrozole (Femara) — to help suppress ...

9. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

   Thus, statins for hyperlipidemia, diuretics, β-adrenergic blockers, ACE inhibitors and angiotensin antagonists for hypertension are permissible. In contrast ...

10. Rilonacept in Subjects with Cardiac Sarcoidosis - Mayo Clinic

    antagonist therapy over the course of the study. 5. Known claustrophobia, or difficulty completing prior PET scan procedure(s) 6. Left ventricular end ...